Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 6 chart positions in 6 markets.
By chart position
- 🇯🇵JP · Medicine#16100K to 300K
- 🇰🇷KR · Medicine#20100K to 300K
- 🇮🇳IN · Medicine#1131K to 10K
- 🇹🇼TW · Medicine#813K to 10K
- 🇹🇷TR · Medicine#169500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
144K to 438K🎙 Biweekly cadence·301 episodes·Long inactive - Monthly Reach
Unique listeners across all episodes (30 days)
205K to 626K🇯🇵48%🇰🇷48%🇮🇳2%+3 more - Active Followers
Loyal subscribers who consistently listen
62K to 188K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Podcast 301: Monkeypox — what to look for, how to treat
Aug 19, 2022
17m 28s
Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer
Aug 11, 2022
9m 32s
Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial
Aug 9, 2022
14m 58s
Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2
Aug 2, 2022
14m 08s
Podcast 297: Forget about all that vitamin D testing!!
Jul 28, 2022
12m 59s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 8/19/22 | Podcast 301: Monkeypox — what to look for, how to treat | A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. This time, we look to New York for guidance on recognizing and treating monkeypox. Dr. Eric Meyerowitz of Montefiore and Dr. Stephen Baum of Einstein will lead you through the monkeypox thicket in a 17-minute chat. Included below is information for patients as well as links to some key […] | 17m 28s | ||||||
| 8/11/22 | Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer | A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. We’re back with another interview from this year’s IASLC conference. This time, Christine Sadlowski and Dr. Julia Rotow interview Dr. Mariano Provencio about the survival outcomes from the NADIM II trial. In that trial, patients with resectable stage III AB non-small cell lung cancer received nivolumab plus chemotherapy […] | 9m 32s | ||||||
| 8/9/22 | Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial | A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. Interim results on overall survival in phase 3 of the IMpower010 trial were presented at this year’s meeting of the International Assosciation for the Study of Lung Cancer (IASLC). As part of the NEJM Group’s coverage of the conference, Christine Sadlowski interviewed the presenter, Dr. Enriqueta Felip. […] | 14m 58s | ||||||
| 8/2/22 | Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2 | A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE AT THIS LINK. In treating most exacerbations of chronic obstructive pulmonary disease (COPD) the usual regimen consists of prednisone plus 5- to 7-days of antibiotics. But what if a shorter course of antibiotic therapy would do? That would be both convenient for patients and less likely to promote […] | 14m 08s | ||||||
| 7/28/22 | Podcast 297: Forget about all that vitamin D testing!! | A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. THE USUAL AUDIO FILE IS AVAILABLE BELOW Steven Cummings has co-written a take-no-prisoners editorial in the New England Journal of Medicine. The topic? Vitamin D supplements. The conclusion? “…providers should stop screening for 25-hydroxyvitamin D levels or recommending vitamin D supplements, and people should stop taking vitamin D […] | 12m 59s | ||||||
| 7/20/22 | Podcast 296: A roundtable on the question, Why are young internists flocking to the hospitalist practice style? | A VIDEO RECORDING OF THIS ROUNDTABLE IS AVAILABLE CLICK HERE. THE USUAL AUDIO FILE IS AVAILABLE BELOW Your host is old enough to remember when hospital corridors featured physicians with little black bags, scurrying around to see their patients. That’s no longer true, of course. Most of the physicians seen in those corridors these days are white-coated employees. The […] | 29m 38s | ||||||
| 7/6/22 | Podcast 295: How should clinicians manage severe (but asymptomatic) carotid artery stenosis while awaiting CREST-2’s results? | CREST-2’s results are probably more than a year away. In the meantime, what to do about diagnosed severe (but asymptomatic) carotid stenosis? Recent results suggest that medical management compares favorably with the surgical approach. In this edition, we address the question with a conversation between Dr. Allan Brett, NEJM Journal Watch‘s editor-in-chief, and Dr. Seemant Chaturvedi, […] | 15m 45s | ||||||
| 6/29/22 | Podcast 294: PD-1 blockade in locally advanced rectal cancer | Locally advanced rectal cancer usually receives a three-part treatment: chemotherapy followed by radiotherapy and then surgery. In a small-cohort study presented at this year’s ASCO conference researchers used a PD-1 inhibitor — dostarlimab — every three weeks for 6 months against the disease. All patients had mismatch repair deficient tumors. No other treatments were needed however, […] | 13m 08s | ||||||
| 6/27/22 | Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate | Patients with metastatic breast cancer whose tumors express low levels of HER2 are generally classified and treated as having HER2-negative disease. However, Dr. Shanu Modi of the Memorial Sloan Kettering Cancer Center and a group of international collaborators explored the use of a monoclonal antibody–drug conjugate (trastuzumab–deruxtecan) in patients with disease they classify as HER2-“low.” Compared […] | 11m 24s | ||||||
| 6/17/22 | Podcast 292: Informed consent and apnea testing for death — or — What is death, anyway? | Apnea testing is part of the protocol used to determine whether a patient is dead according to neurologic criteria. The question is, do clinicians need to obtain consent to proceed? In a fascinating 15-minute chat, two intensivists, Drs. Patricia Kritek and Robert Truog, discuss that question and another, larger one: what is death, anyway? Their back-and-forth […] | 14m 40s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 5/24/22 | Podcast 291: Unionized nursing homes had lower mortality during Covid-19 | In the early waves of the Covid-19 pandemic why did patients in unionized nursing homes, have a roughly 10% lower rate of mortality than those in non-unionized ones? A report in Health Affairs tries to sort out the possible reasons. Listen to our 13-minute interview, which raises the question: Should you send your patients to non-unionized facilities? […] | 13m 16s | ||||||
| 5/8/22 | Podcast 290: USPSTF’s new take on aspirin and primary prevention of CVD | The U.S. Preventive Services Task Force recently issued its sixth set of guidelines on using daily aspirin to prevent cardiovascular disease. The guidelines appeared in JAMA — whose editors asked our guest, Dr. Allan Brett, to write an editorial evaluation. This edition carries Brett’s advice on using the new guidelines in daily clinical practice. Brett’s JAMA editorial USPSTF […] | 14m 33s | ||||||
| 5/4/22 | Podcast 289: Saline versus balanced crystalloids — what to choose | Saline or balanced crystalloids? The question of which resuscitation fluid to use in clinical practice seems to have been settled by recent research findings — or at least settled in favor of balanced crystalloids. But wait, our guests see slight differences that may affect your choice. Patricia Kritek practices critical care medicine at the University of […] | 16m 22s | ||||||
| 4/21/22 | Podcast 288: Following up with a Ukrainian narcologist | Spend 15 minutes with Dr. Natalia Shevchuk, whom we interviewed by candlelight last month. She is sheltering in the Odessa region now, having left the Donetsk area. This time, she relates how she lost a colleague in Russia’s attack on the Kramatorsk railway station and found another she’d feared lost in Mariupol. She told us that […] | 15m 28s | ||||||
| 4/10/22 | Podcast 287: Thinking about quality-of-life in migraine | During the American Academy of Neurology’s 2022 meeting in Seattle, Dr. Richard Lipton of Albert Einstein College of Medicine took questions from Dr. Teshamae Monteith (U. Miami) and Joe Elia. Lipton’s group sought to characterize the impact of patients’ monthly headache days on their quality of life, especially the role of depression, allodynia, and anxiety. (Read […] | 13m 58s | ||||||
| 3/21/22 | Podcast 286: Talking about addiction treatment by candlelight from Ukraine’s Donetsk region | Dr. Natalia Shevchuk (pictured above) treats substance use disorders in Ukraine’s Donetsk region. Her face is candlelit because her town is under curfew, and people aren’t allowed to put on their room lights (if they have electricity) in the hours of darkness, lest Russian bombardments use the lights as guides. She talked with Dr. Ali Raja […] | 19m 17s | ||||||
| 3/11/22 | Podcast 285: GERD’s revised guidelines — an internist and a gastroenterologist discuss them. | Gastroesophageal reflux, or GERD, was the focus of a revised set of guidelines issued in January in the American Journal of Gastroenterology. Given the frequency of that condition in primary care clinics, internist and NEJM Journal Watch editor-in-chief Allan Brett proposed a discussion about the practical application of these guidelines with David Bjorkman. Dr. Bjorkman, […] | 23m 44s | ||||||
| 3/8/22 | Podcast 284: The clinical situation in Ukraine | Some 85 years ago Guernica was bombed, and after that came Dresden, Coventry, Hiroshima, Bach Mai, and the rest. This episode of Clinical Conversations asks how it might be possible to help clinicians under bombardment in Ukraine. As you will hear, one hospital in Chernihiv keeps all but essential staff away from its buildings when […] | 19m 53s | ||||||
| 2/22/22 | Podcast 283: More data — this time from the U.K. — about post-Covid vaccination | You want more evidence that post-recovery vaccination against Covid-19 reinfection helps? Here is a careful study from the U.K. that followed some 35,000 health care workers — initially without symptoms — in over 100 institutions there. Starting in June 2020 the SIREN study tested these people regularly, with blood sampling every month and nasal swabs […] | 10m 42s | ||||||
| 2/17/22 | Podcast 282: Vaccination after Covid-19 recovery prolongs natural immunity to reinfection | Governments’ directives about how and when to vaccinate people who’ve recovered from Covid-19 vary widely. But, according to this episode’s guest, Dr. Ronen Arbel, they all say they don’t have enough evidence to set firm policy. So, Arbel and his colleagues set out to collect evidence from some 150,000 patients’ records in Israel who’d recovered […] | 14m 53s | ||||||
| 2/5/22 | Podcast 281: Drug Costs — What’s “The Right Price” for prescription pharmaceuticals? | Why can’t the U.S. control prescription drug pricing as they do in the U.K., where per-capita spending is less than half our level? In a capitalist democracy, many parties — the drug companies, medical associations, consumer groups — get to lobby their points of view. Is the problem intractable, or just an exercise in chaos? Our three […] | 26m 28s | ||||||
| 1/14/22 | Podcast 280: MIS-C after Covid-19 in adolescents — can vaccination prevent it? | Multisystem inflammatory syndrome in children (or MIS-C) is a serious complication of Covid-19 infection, usually showing up about a month after infection. CDC worked with several hospitals around the U.S. to discern whether vaccination in adolescents would lessen the likelihood of this outcome. A vaccine hadn’t yet been approved, as it now is, for kids between […] | 15m 40s | ||||||
| 9/27/21 | Podcast 279: Age-specific data do better than age-adjusted data in revealing health inequities | Kiarri Kershaw has written a simple letter in JACC — the Journal of the American College of Cardiology. The letter conveys a strong message: health inequities don’t act uniformly across one’s lifetime. Her examination of Black versus white mortality from all causes and from cardiovascular causes with the use of age-specific data shows places in […] | 6m 26s | ||||||
| 4/27/21 | Podcast 278: Where equity and community health intersect — a conversation with Joseph Betancourt | An internist at Massachusetts General Hospital, Dr. Joseph Betancourt also runs their program on equity and community health. In this, the final entry in our four-interview exploration of race and clinical equity, Betancourt talks about the need for medical institutions to pay attention to what’s happening in their patients’ communities. To that end, MGH has a […] | 16m 40s | ||||||
| 4/26/21 | Podcast 277: Race and clinical equity — know your patients — a conversation with Karen Dorsey Sheares | Dr. Sheares talks about her experience with inequities. She believes that clinicians should aspire to be students of their patients as well as of the pathophysiology of the diseases their patients present with. Listen in. Running time: 20 minutes | 20m 51s | ||||||
Showing 25 of 301
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
8 placements across 6 markets.
Chart Positions
8 placements across 6 markets.